Recall Z-1018-2022— Becton Dickinson & Co.
Class II · Terminated
Class II FDA medical device recall by Becton Dickinson & Co., initiated 2022-03-09, terminated 2024-01-19. FDA's recall record names no specific 510(k) clearance for this event. Product: BD Synapsys Microbiology Informatics Solution, Catalog Number 444150, Software Version 4.10. Reason: When updating BD Kiestra customers to BD Synapsys version 4.10, the custom antibiotic codes set by the customer are overwritten with the BD default antibiotic codes..
- Recalling firm
- Becton Dickinson & Co.
- Classification
- Class II
- Status
- Terminated
- Initiated
- 2022-03-09
- Terminated
- 2024-01-19
- Firm location
- Sparks, MD, United States
Product description
BD Synapsys Microbiology Informatics Solution, Catalog Number 444150, Software Version 4.10
Reason for recall
When updating BD Kiestra customers to BD Synapsys version 4.10, the custom antibiotic codes set by the customer are overwritten with the BD default antibiotic codes.
Data sourced from openFDA. This site is unofficial and independent of the FDA.